About
Vaccines, Biologics
Areas of Focus
Categories
BiosimilarsBiologics & BiopharmaceuticalVaccineTaiwan
Clinical Trials (20)
View allTotal Trials
20
As Lead Sponsor
18
As Collaborator
2
Total Enrollment
13,450
By Phase
PHASE3: 6PHASE1: 2PHASE2: 8PHASE1/PHASE2: 2PHASE4: 1
By Status
COMPLETED: 17UNKNOWN: 2RECRUITING: 1
Clinical Trials Pipeline20 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT07178522Lead Sponsor
A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen®) in Children Aged 6 to <10 Years Compared to Children Aged 2 to <6 Years
PHASE3Recruiting
378 participants
Started: Jun 25, 2025 · Completed: Jul 1, 2026
NCT05198596Lead Sponsor
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 in Adults Aged 18 Years and Above
PHASE3Completed
250 participants
Started: Jul 30, 2022 · Completed: Mar 30, 2023
NCT05426343Lead Sponsor
A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Vaccine Compared With AZD1222
PHASE3Completed
200 participants
Started: Jul 9, 2022 · Completed: Jan 7, 2023
NCT05216601Lead Sponsor
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of MVC-COV1901 or MVC-COV1901(Beta) Against COVID-19
PHASE1Completed
107 participants
Started: May 6, 2022 · Completed: Nov 30, 2022
NCT05197153Lead Sponsor
A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19
PHASE2Completed
804 participants
Started: Jan 22, 2022 · Completed: Oct 28, 2022
Locations (1)
Headquarters
Taipei, Taiwan
Map
Loading map...